These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10369595)

  • 1. Iris color as a prognostic factor in ocular melanoma.
    Regan S; Judge HE; Gragoudas ES; Egan KM
    Arch Ophthalmol; 1999 Jun; 117(6):811-4. PubMed ID: 10369595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma.
    Li W; Gragoudas ES; Egan KM
    Arch Ophthalmol; 2003 Jan; 121(1):68-72. PubMed ID: 12523887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
    Papakostas TD; Lane AM; Morrison M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2017 Nov; 135(11):1191-1196. PubMed ID: 29049518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.
    Egan KM; Ryan LM; Gragoudas ES
    Arch Ophthalmol; 1998 Mar; 116(3):366-70. PubMed ID: 9514491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma.
    Li W; Gragoudas ES; Egan KM
    Arch Ophthalmol; 2000 Aug; 118(8):1066-70. PubMed ID: 10922199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.
    Diener-West M; Reynolds SM; Agugliaro DJ; Caldwell R; Cumming K; Earle JD; Hawkins BS; Hayman JA; Jaiyesimi I; Jampol LM; Kirkwood JM; Koh WJ; Robertson DM; Shaw JM; Straatsma BR; Thoma J;
    Arch Ophthalmol; 2005 Dec; 123(12):1639-43. PubMed ID: 16344433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease.
    Augsburger JJ; Gamel JW; Shields JA; Markoe AM; Brady LW
    Ophthalmology; 1987 Sep; 94(9):1173-7. PubMed ID: 3684235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color.
    Wierenga APA; Brouwer NJ; Gelmi MC; Verdijk RM; Stern MH; Bas Z; Malkani K; van Duinen SG; Ganguly A; Kroes WGM; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
    Ophthalmology; 2022 Apr; 129(4):421-430. PubMed ID: 34780841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.
    Am J Ophthalmol; 1998 Jun; 125(6):779-96. PubMed ID: 9645716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis.
    Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
    Br J Ophthalmol; 2019 Mar; 103(3):332-337. PubMed ID: 29777046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Am J Ophthalmol; 1999 May; 127(5):579-89. PubMed ID: 10334352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
    Tran E; Ma R; Paton K; Blackmore E; Pickles T
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
    Hawkins BS;
    Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The regression behavior of choroid melanoma following radiotherapy--a new prognostic parameter?].
    Guthoff R; Haase J; von Domarus D; Draeger J; Lauritzen K
    Klin Monbl Augenheilkd; 1990 Jan; 196(1):6-10. PubMed ID: 2313997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival.
    Damato BE; Heimann H; Kalirai H; Coupland SE
    JAMA Ophthalmol; 2014 May; 132(5):605-13. PubMed ID: 24626610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
    Khan S; Finger PT; Yu GP; Razzaq L; Jager MJ; de Keizer RJ; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
    Arch Ophthalmol; 2012 Jan; 130(1):57-64. PubMed ID: 21911649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.